Aug 13, 2020
Global Hepatitis B Tests Industry 2015-2030: COVID-19 Impact, Revenues by Segment, Total Procedures, Units, ASPs, and Market Values by Segment
Mar 27, 2020
Global Genital Herpes Pipeline Review, H1 2020
Mar 13, 2020
Insights Into the Antiviral Therapeutics Market, 2018-2028 - Featuring 194 Company Profiles and 175 Collaborations
Mar 12, 2020
Advaite Produces COVID-19 Rapid Response Diagnostic Testing Kits
Mar 09, 2020
Demiurge AI Discovers the Complete Aetiology of COVID-19 and the Optimal Treatment Strategy for COVID-19
Feb 26, 2020
Clinical Trial of Ganovo® and Ritonavir Combination Therapy on Novel Coronavirus Pneumonia
Jan 14, 2020
Nurx Introduces Convenient & Stigma-Free Treatment for Herpes
Nov 28, 2019
The global varicella live vaccine market was valued at $2,714 million in 2018, and is expected to reach $4,222 million by 2026, registering a CAGR of 5.7% from 2019 to 2026
Nov 12, 2019
Global hepatitis test solution/diagnosis market is expected to grow with a CAGR of 4.1% over the forecast period from 2019-2025
Oct 29, 2019
Market Share in Nanotechnology and Nanomedicine for Treatment of Viral Infections Could Reach Tens of Billion Dollars
Oct 22, 2019
OrigiMed: The largest cohort study on HBV-Related hepatocellular carcinoma in China released in Cell
Aug 26, 2019
NanoViricides, Inc. Has Filed its Annual Report, Company Advancing Rapidly Towards First IND
Aug 14, 2019
Global Antiviral Therapeutics Delivery Research Report 2019: Analysis of Markets, 2018-2019 & Forecasts 2019-2028
Aug 05, 2019
NanoViricides Reports Its First Drug Candidate is on Track with GLP Safety/Toxicology Studies toward Human Clinical Trials
Aug 05, 2019
Squarex Announces Positive Results from Completed Phase 2 Study of SQX770 in the Prevention of Recurrent Herpes Labialis
Jul 30, 2019
New Startup Biotech Company Plans to Test Promising Herpes Vaccine for Both HSV-1 and HSV-2
Jul 11, 2019
Hepatitis B in the United States: In-depth Market Analysis 2014-2019 and Forecast to 2024
Jul 08, 2019
Intent Solutions Joins University of Kentucky Program to Eliminate Hepatitis C in Appalachia
Jul 01, 2019
Squarex Appoints Biopharmaceutical Industry Veteran Jack V. Talley as Chief Executive Officer
Jun 04, 2019
Antiviral Therapeutics Markets, 2028